Literature DB >> 7217331

Clostridium difficile in relation to enteric bacterial pathogens.

E Falsen, B Kaijser, L Nehls, B Nygren, A Svedhem.   

Abstract

All feces samples (n = 2,390) sent to the Bacteriological Laboratory, Göteborg, Sweden over 43 days were, in addition to the standard procedure, cultivated to detect Clostridium difficile by using a special selective medium. C. difficile was found in 81 of the 2,390 samples (3%). These 81 samples represented 56 patients. Fifty of the 56 patients had diarrhea. In 20 of the 56 patients (36%), Salmonella, Campylobacter, or Yersinia were also found. Of the 2,390 samples 252 (11%) from 132 patients revealed positive isolations of Salmonella, Shigella, Campylobacter, or Yersinia in comparison to 3% for C. difficile alone. This result suggests that C. difficile can easily be isolated with proper techniques. Concomitant isolations of more than one bacterial pathogen in cases of gastroenteritis were often found for C. difficile. The theory presented here is that any change of the normal bacterial fecal flora due to such causes as antimicrobial treatment or enteric infections like Salmonella increases the possibilities of isolating C. difficile. The causative significance of C. difficile might in most cases be doubtful. The majority of cases with diarrhea and C. difficile were self-healing and not severe. Only 2 cases of 56 had severe diarrhea with extended engagement of the colonic mucous membrane, but with no signs of pseudomembranes.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7217331      PMCID: PMC273578          DOI: 10.1128/jcm.12.3.297-300.1980

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

1.  Campylobacter enteritis: a "new" disease.

Authors:  M B Skirrow
Journal:  Br Med J       Date:  1977-07-02

Review 2.  Pseudomembranous enterocolitis (antibiotic-related colitis).

Authors:  J G Bartlett; S L Gorbach
Journal:  Adv Intern Med       Date:  1977

3.  The survival time for different bacteria in various transport media.

Authors:  B Gästrin; L O Kallings; A Marcetic
Journal:  Acta Pathol Microbiol Scand       Date:  1968

4.  Effect of phenoxymethylpenicillin and clindamycin on the oral, throat and faecal microflora of man.

Authors:  A Heimdahl; C E Nord
Journal:  Scand J Infect Dis       Date:  1979

5.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

Authors:  J G Bartlett; T W Chang; M Gurwith; S L Gorbach; A B Onderdonk
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

6.  Colitis induced by Clostridium difficile.

Authors:  J G Bartlett; T Chang; N S Taylor; A B Onderdonk
Journal:  Rev Infect Dis       Date:  1979 Mar-Apr

7.  Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea.

Authors:  M R Keighley; D W Burdon; Y Arabi; J A Williams; H Thompson; D Youngs; M Johnson; S Bentley; R H George; G A Mogg
Journal:  Br Med J       Date:  1978-12-16

8.  Selective and differential medium for isolation of Clostridium difficile.

Authors:  W L George; V L Sutter; D Citron; S M Finegold
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

9.  Clostridium difficile and the aetiology of pseudomembranous colitis.

Authors:  H E Larson; A B Price; P Honour; S P Borriello
Journal:  Lancet       Date:  1978-05-20       Impact factor: 79.321

10.  Gastrointestinal side effects of clindamycin and ampicillin therapy.

Authors:  R H Lusk; F R Fekety; J Silva; T Bodendorfer; B J Devine; H Kawanishi; L Korff; D Nakauchi; S Rogers; S B Siskin
Journal:  J Infect Dis       Date:  1977-03       Impact factor: 5.226

  10 in total
  14 in total

1.  Enterotoxins from Clostridium difficile; diarrhoeogenic potency and morphological effects in the rat intestine.

Authors:  J Torres; E Jennische; S Lange; I Lönnroth
Journal:  Gut       Date:  1990-07       Impact factor: 23.059

2.  A selective enrichment broth for the isolation of Clostridium difficile.

Authors:  S O'Farrell; M Wilks; J Q Nash; S Tabaqchali
Journal:  J Clin Pathol       Date:  1984-01       Impact factor: 3.411

3.  Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc.

Authors:  H C Krivan; G F Clark; D F Smith; T D Wilkins
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

4.  Intestinal colonization of infant hamsters with Clostridium difficile.

Authors:  R D Rolfe; J P Iaconis
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

5.  Clostridium difficile and cytotoxin in routine faecal specimens.

Authors:  J Q Nash; B Chattopadhyay; J Honeycombe; S Tabaqchali
Journal:  J Clin Pathol       Date:  1982-05       Impact factor: 3.411

6.  Isolation of Clostridium difficile from hospitalized patients without antibiotic-associated diarrhea or colitis.

Authors:  N M Varki; T I Aquino
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

7.  Clostridium difficile in association with sporadic diarrhoea.

Authors:  R P Brettle; I R Poxton; J M Murdoch; R Brown; M D Byrne; J G Collee
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-23

8.  Intestinal occurrence of Campylobacter fetus subspecies jejuni and Clostridium difficile in children in Sweden.

Authors:  A Svedhem; B Kaijser; I MacDowall
Journal:  Eur J Clin Microbiol       Date:  1982-02       Impact factor: 3.267

Review 9.  Laboratory diagnosis of Clostridium difficile-associated diarrhoea.

Authors:  R A Bowman; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-08       Impact factor: 3.267

10.  Clostridium difficile in general practice and community health.

Authors:  T V Riley; V Wymer; V W Bamford; R A Bowman
Journal:  J Hyg (Lond)       Date:  1986-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.